HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Giuseppe Querques Selected Research

COVID-19

1/2022Effect of COVID-19-related lockdown on ophthalmic practice in Italy: A report from 39 institutional centers.
3/2021The COVID-19 Pandemic Has Had Negative Effects on Baseline Clinical Presentation and Outcomes of Patients with Newly Diagnosed Treatment-Naïve Exudative AMD.
12/2020Impact of COVID-19 on outpatient visits and intravitreal treatments in a referral retina unit: let's be ready for a plausible "rebound effect".

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Giuseppe Querques Research Topics

Disease

55Macular Degeneration (Age-Related Maculopathy)
03/2024 - 02/2009
48Macular Edema
05/2024 - 02/2008
41Choroidal Neovascularization
10/2023 - 02/2008
26Diabetic Retinopathy (Retinopathy, Diabetic)
02/2024 - 01/2009
26Central Serous Chorioretinopathy
12/2023 - 04/2014
17Atrophy
08/2023 - 10/2010
13Retinal Vein Occlusion
12/2022 - 01/2013
12Myopia
12/2023 - 01/2008
11Retinal Detachment (Retinal Detachments)
05/2022 - 02/2008
9Ischemia
02/2024 - 01/2013
9Microaneurysm
01/2021 - 01/2012
7Angioid Streaks
03/2024 - 06/2010
7Geographic Atrophy
01/2023 - 09/2009
7Retinal Perforations
05/2022 - 01/2008
7Ganglion Cysts (Ganglion)
01/2022 - 01/2015
6Hemorrhage
10/2023 - 09/2014
6Epiretinal Membrane (Epiretinal Membranes)
08/2023 - 04/2008
5Polypoidal Choroidal Vasculopathy
12/2023 - 01/2008
5Cysts
01/2022 - 03/2010
5Telangiectasis (Telangiectasia)
01/2021 - 01/2012
5Vision Disorders (Hemeralopia)
10/2020 - 07/2011
4Type 2 Diabetes Mellitus (MODY)
01/2023 - 01/2015
4Hypertension (High Blood Pressure)
06/2022 - 06/2014
4Blindness (Hysterical Blindness)
07/2020 - 01/2013
4Stargardt Disease
09/2010 - 01/2009
3Retinal Diseases
08/2023 - 01/2011
3Retinitis Pigmentosa (Pigmentary Retinopathy)
03/2023 - 04/2009
3Phototoxic Dermatitis (Phototoxicity)
05/2022 - 04/2008
3Cicatrix (Scar)
01/2022 - 07/2011
3COVID-19
01/2022 - 12/2020
3Glaucoma
01/2022 - 11/2017
3Edema (Dropsy)
01/2020 - 04/2009
3White Dot Syndromes
11/2018 - 02/2010
3Vitelliform Macular Dystrophy
08/2018 - 09/2008
3Inflammation (Inflammations)
01/2017 - 01/2014
2Leukostasis
04/2022 - 05/2020
2Disease Progression
01/2021 - 01/2017
2Lymphoma (Lymphomas)
05/2020 - 11/2019
2Uveitis
01/2020 - 01/2019
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2020 - 07/2017
2Hamartoma
01/2019 - 07/2010
2Retinal Telangiectasis
10/2017 - 01/2012
2Sarcoidosis (Schaumann Disease)
08/2016 - 06/2014
2Retinoschisis (Retinoschisis, Juvenile)
01/2008 - 09/2005
1Posterior Uveitis
12/2023
1Scleritis (Episcleritis)
11/2023
1Degenerative Myopia
11/2023
1Myotonic Dystrophy (Dystrophia Myotonica)
08/2023
1Infarction (Infarctions)
05/2023
1Leber Hereditary Optic Atrophy (Leber's Hereditary Optic Neuropathy)
01/2023
1Erectile Dysfunction
01/2023
1Optic Nerve Diseases (Optic Neuropathy)
01/2023
1Aneurysm (Aneurysms)
12/2022

Drug/Important Bio-Agent (IBA)

101Retinaldehyde (Retinal)IBA
12/2023 - 04/2008
38Fluorescein (Funduscein)FDA LinkGeneric
10/2023 - 09/2005
34Ranibizumab (Lucentis)FDA Link
05/2020 - 02/2008
30Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2024 - 02/2009
17Dexamethasone (Maxidex)FDA LinkGeneric
05/2024 - 01/2012
15Indocyanine Green (Cardio-Green)FDA LinkGeneric
01/2023 - 09/2005
121-phenyl-3,3-dimethyltriazene (PDT)IBA
08/2023 - 06/2010
11Biomarkers (Surrogate Marker)IBA
02/2024 - 08/2020
5Coloring Agents (Dyes)IBA
05/2022 - 03/2010
5Adrenal Cortex Hormones (Corticosteroids)IBA
04/2022 - 01/2013
5afliberceptIBA
06/2021 - 08/2016
4Endothelial Growth FactorsIBA
03/2024 - 09/2009
4Eplerenone (Inspra)FDA LinkGeneric
05/2023 - 06/2018
4Retinal Pigments (Pigments, Visual)IBA
05/2022 - 05/2017
4Colloids (Colloid)IBA
06/2021 - 03/2015
3Verteporfin (Visudyne)FDA Link
08/2023 - 06/2010
3Silicone OilsIBA
07/2020 - 02/2013
3SteroidsIBA
11/2018 - 01/2014
3LipofuscinIBA
01/2017 - 01/2009
3Docosahexaenoic AcidsIBA
01/2016 - 07/2010
3pegaptanib (Macugen)FDA Link
12/2011 - 04/2009
3Bevacizumab (Avastin)FDA Link
10/2010 - 07/2008
2Biosimilar PharmaceuticalsIBA
07/2023 - 02/2023
2Phenobarbital (Luminal)FDA Link
10/2021 - 01/2017
2LipidsIBA
01/2021 - 09/2014
2Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
06/2014 - 01/2011
1phytobacteriomycin (PBM)IBA
12/2023
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
03/2023
1Vascular Endothelial Growth FactorsIBA
03/2023
1brolucizumabIBA
01/2023
1SDDSIBA
01/2023
1PM 01183IBA
12/2022

Therapy/Procedure

18Therapeutics
02/2024 - 07/2011
17Lasers (Laser)
09/2022 - 01/2008
16Photochemotherapy (Photodynamic Therapy)
08/2023 - 12/2009
15Injections
01/2023 - 03/2010
15Intravitreal Injections
06/2021 - 02/2008
8Vitrectomy
05/2022 - 02/2013
6Light Coagulation
01/2019 - 01/2008
5Traction
05/2022 - 01/2008
4Aftercare (After-Treatment)
05/2021 - 06/2014
3Drug Therapy (Chemotherapy)
12/2022 - 01/2013
3Vitreoretinal Surgery
07/2020 - 01/2017
2Decompression
01/2021 - 07/2004
2Retreatment
06/2015 - 09/2011
2Slit Lamp
05/2014 - 04/2008
1Low-Level Light Therapy (LLLT)
12/2023